Skip to main content

Table 6 Details of top six hypermethylated genes obtained from MeDIP-sequencing

From: Comprehensive DNA methylation profiling by MeDIP-NGS identifies potential genes and pathways for epithelial ovarian cancer

Hypermethylated Genes

Gene name

Feature

log2FoldChange

p-value

Status in ovarian cancer

POLR3B

RNA polymerase III subunit B

Promoter 1k

0.66

0.006106

Not reported in ovarian cancer

PLXND1

Plexin D

Promoter 1k

0.69

0.000595

Only 1 study reported mentioning regulation of Epithelial-Mesenchymal transition by PLXND1

GIGYF2

Grb 10-interacting GYF protein 2

Promoter 1k

0.33

0.033441

Not reported in ovarian cancer

STK4

Serine/Threonine kinase 4

Promoter 3k

0.5

0.019861

Reported as downregulated in OC

CRKL

CRK-like proto oncogene

Promoter 3k

0.78

0.003422

Two studies were reported demonstrating the regulation of EMT through ERK signalling pathwway. Another study reported its overexpression.

BMP2

Bone morphogenetic protein 2

Promoter 3k

0.5

0.023133

Few studies were reported. One of them had shown a downregulated expression.